Radiological Evaluation of Sarcopenia in Patient Received Chemotherapy

Not yet recruiting

• Conditions: Sarcopenia

• Registration Number: NCT06166134
• Lead Sponsor: Assiut University

Brief Summary

Radiological evaluation of sarcopenia in patients receiving chemotherapy

Detailed Description

Evaluation of muscle mass by using sonoelastography and computed tomography

Study Timeline

• Status Verified: 2023-12
• Study First Submitted: 2023-12-02
• Study First Submitted QC: 2023-12-08
• Last Update Submitted: 2023-12-08
• Study First Posted: 2023-12-12
• Last Update Posted: 2023-12-12
• Study Start: 2024-01
• Primary Completion: 2025-04
• Study Completion: 2025-04

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 72

Inclusion Criteria

• all cancer patients receiving chemotherapy referred to radiodiagnosis department for routine examination Patients must be between 18 and

Exclusion Criteria

• Previous or current history of any musculoskeletal or neurological disorder including strokes.
• Systemic atrophy affecting CNS ( Huntington disease ,hereditary ataxia ,spinal muscular disorder and related syndromes ,post polio syndrome )
• Central nervous system demyelinating disease ( Multiple sclerosis , acute disseminated demyelinated syndromes..
• Corticosteroids undertaken currently or for the past 3 years with doses >5mg/day.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Radiological evaluation of sarcopenia in patients receiving chemotherapy	April 2025	Using sonoelastography and computed tomography in evaluation of muscle mass in patients received chemotherapy by measurement of muscle thickness ,echogencity ,cross sectional area ,fasicle length,pennation angle, strain ratio,shear wave velocity